Cargando…

Stattic alleviates acute hepatic damage induced by LPS/d-galactosamine in mice

Increasing evidence indicates that signal transducer and activator of transcription 3 (STAT3), a vital transcription factor, plays crucial roles in the regulation of inflammation. STAT3 has become a novel therapeutic target for intervention in inflammation-related disorders. However, it remains uncl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Sijia, Hu, Kai, Li, Longjiang, Shen, Yi, Huang, Jiayi, Tang, Li, Zhang, Li, Shao, Ruyue, Lu, Han, Yang, Yongqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882804/ https://www.ncbi.nlm.nih.gov/pubmed/33576722 http://dx.doi.org/10.1177/1753425920988330

Ejemplares similares

Succinate dehydrogenase inhibitor dimethyl malonate alleviates LPS/d-galactosamine-induced acute hepatic damage in mice
por: Yang, Yongqiang, et al.
Publicado: (2019)

Luzindole attenuates LPS/d-galactosamine-induced acute hepatitis in mice
por: Luo, Yisheng, et al.
Publicado: (2019)

REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice
por: Shao, Ruyue, et al.
Publicado: (2021)

Protective Effect of Luteolin on D-Galactosamine (D-Gal)/Lipopolysaccharide (LPS) Induced Hepatic Injury by in Mice
por: Pu, Yiwei, et al.
Publicado: (2021)

Protective Effect of Danhong Injection on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice
por: Wang, Ying, et al.
Publicado: (2014)

Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge
por: BAI, LI, et al.
Publicado: (2016)

Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to LPS/Galactosamine Liver Injury and Protection by Betaine Administration
por: Rasineni, Karuna, et al.
Publicado: (2020)

Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice
por: WU, YI-HANG, et al.
Publicado: (2014)

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice
por: Wu, Yi-Long, et al.
Publicado: (2022)

The sirtuin 1 activator SRT1720 alleviated endotoxin-induced fulminant hepatitis in mice
por: Zhou, Dan, et al.
Publicado: (2021)

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice
por: Okumura, Akinori, et al.
Publicado: (2017)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice
por: Mohamadi-Zarch, Seyed-Mahdi, et al.
Publicado: (2021)

Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
por: Mu, Wenwen, et al.
Publicado: (2022)

Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016)

Blocking DNA Damage Repair May Be Involved in Stattic (STAT3 Inhibitor)-Induced FLT3-ITD AML Cell Apoptosis
por: Luo, Yuxuan, et al.
Publicado: (2021)

Arbutin Alleviates LPS Induced Sepsis Pneumonia in Mice
por: Bian, Xiang-Xiang, et al.
Publicado: (2022)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Deficiency of Ninjurin1 attenuates LPS/D‐galactosamine‐induced acute liver failure by reducing TNF‐α‐induced apoptosis in hepatocytes
por: Kim, Min Woo, et al.
Publicado: (2022)

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice
por: Feng, Bo, et al.
Publicado: (2009)

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
Publicado: (1987)

Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023)

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017)

Lysimachiae Herba Inhibits Inflammatory Reactions and Improves Lipopolysaccharide/D-Galactosamine-Induced Hepatic Injury
por: Jeong, Yun Hee, et al.
Publicado: (2021)

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway
por: Xu, Gang, et al.
Publicado: (2017)

The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression
por: Poria, Dipak K., et al.
Publicado: (2020)

Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic – A STAT3 Dimerization Blocker
por: Fong, Stephanie Sally, et al.
Publicado: (2022)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Mao, Jingxin, et al.
Publicado: (2018)

Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure
por: Feng, Lei, et al.
Publicado: (2017)

Hepatoprotective activity of a new polyherbal formulation against paracetamol and D-galactosamine induced hepatic toxicity
por: Khan, Mohammad Ahmed, et al.
Publicado: (2015)

Heat-inactivated Lacticaseibacillus paracasei N1115 alleviates the damage due to brain function caused by long-term antibiotic cocktail exposure in mice
por: Zhang, Yujie, et al.
Publicado: (2022)

Protective Properties of Laggera alata Extract and its Principle Components Against d-Galactosamine-Injured Hepatocytes
por: Wu, Yi-Hang, et al.
Publicado: (2012)

Pretreatment With Bacillus cereus Preserves Against D-Galactosamine-Induced Liver Injury in a Rat Model
por: Li, Ya-Ting, et al.
Publicado: (2019)

NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes
por: Jia, Fang, et al.
Publicado: (2021)

Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure
por: Wang, Kaicen, et al.
Publicado: (2020)

Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells
por: Mohammadian, Jamal, et al.
Publicado: (2016)

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2020)

BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice
por: Quan, Jishu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_480mq55aaapa8gpejjl5jbb98m